Skip to main content
. 2008 Jul 29;19(12):2020–2025. doi: 10.1093/annonc/mdn427

Figure 3.

Figure 3.

Distribution of residual cancer burden in (A) hormone receptor-positive and (B) hormone receptor-negative cases.